Unique ID issued by UMIN | UMIN000036243 |
---|---|
Receipt number | R000041003 |
Scientific Title | Clinical study on safety assessment of PRP therapy for iliopsoas impingement after total hip arthroplasty |
Date of disclosure of the study information | 2019/03/18 |
Last modified on | 2019/03/18 10:18:09 |
Clinical study on safety assessment of
PRP therapy for iliopsoas impingement after total hip arthroplasty
Clinical study on safety assessment of
PRP therapy for iliopsoas impingement after total hip arthroplasty
Clinical study on safety assessment of
PRP therapy for iliopsoas impingement after total hip arthroplasty
Clinical study on safety assessment of
PRP therapy for iliopsoas impingement after total hip arthroplasty
Japan |
Patients who is diagnosed iliopsoas impingement after total hip arthroplasty
Orthopedics |
Others
NO
To confirm the safety assessment of PRP therapy for iliopsoas impingement
Safety
Safety
Usefulness
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Other |
Using the PRP
20 | years-old | <= |
Not applicable |
Male and Female
1.Patients who have symptoms for more than 3 months
2.Patients who have continued pain even after taking NSAIDs for 6 week or more and who can not use NSAIDs for asthma and digestive tract ulcer
3. More than 20 years old
4. Other , patients who the doctor has determined that it is suitable for this clinical study
1. Patients with abnormal platelet counts in peripheral blood
2. Person who smokes a lot(Brinkmanindex>600)
3. Treatment with anticoagulants(Warfarin)
4. Uncontrolled diabetes mellitus :HbA1c not lower than 9.0% according to latest laboratory data obtained within 14 days before registration
5. Patients with malignancy
6. Patients less than 6 months after onset of cardiac infarction or cerebral infarction
7. Predictive survival period is less than 1 year
8.Active infectious disease (HBV, HCV, HTLV-1, HIV, syphilis)
9.Dialysis patients
10. Compromised host
11. Requiring continued use of oral corticosteroid therapy
12. Less than 20 years old
13. Doctor has determined that it is not suitable for this clinical study
5
1st name | Yasuhiro |
Middle name | |
Last name | Honma |
Juntendo Hospital, Juntendo university school of medicine
Orthopedic Surgery
113-8431
3-1-3, Hongo, Bunkyo-ku, Tokyo, 113-8431, Japan
03-3813-3111
yhomma@juntendo.ac.jp
1st name | Yasuhiro |
Middle name | |
Last name | Honma |
Juntendo Hospital, Juntendo university school of medicine
Orthopedic Surgery
113-8431
3-1-3, Hongo, Bunkyo-ku, Tokyo, 113-8431, Japan
03-3813-3111
yhomma@juntendo.ac.jp
Juntendo Hospital, Juntendo university school of medicine
Juntendo University
Self funding
Ethical Review Board of Juntendo University Faculty of Medicine
2-1-1, Hongo, Bunkyo-ku, Tokyo, Japan
03-3813-3111
rinri@juntendo.ac.jp
NO
順天堂大学附属順天堂医院(東京都)
2019 | Year | 03 | Month | 18 | Day |
Unpublished
Open public recruiting
2019 | Year | 03 | Month | 14 | Day |
2019 | Year | 03 | Month | 18 | Day |
2019 | Year | 03 | Month | 18 | Day |
2022 | Year | 03 | Month | 31 | Day |
2019 | Year | 03 | Month | 18 | Day |
2019 | Year | 03 | Month | 18 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000041003
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |